Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.048 HKD | -.--% | -.--% | -.--% |
04-01 | Welife Technology's Winding-Up Hearing Further Adjourned | MT |
02-15 | Winding-Up Petition Hearing Against Welife Technology Adjourned to March | MT |
Valuation
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Capitalization 1 | 495 | 325 | 575 | 885.5 | 586.5 |
Enterprise Value (EV) 1 | 282.6 | 731.6 | 830.5 | 1,043 | 666.7 |
P/E ratio | 10.2 x | -2.89 x | -4.32 x | -27.7 x | -84.5 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 0.58 x | 0.5 x | 2.53 x | 2.99 x | 1.92 x |
EV / Revenue | 0.33 x | 1.12 x | 3.65 x | 3.52 x | 2.18 x |
EV / EBITDA | 3.04 x | -39.4 x | -7.02 x | -37.2 x | -84.2 x |
EV / FCF | 8.21 x | 22.1 x | -1,410 x | 20.2 x | 14.1 x |
FCF Yield | 12.2% | 4.52% | -0.07% | 4.94% | 7.11% |
Price to Book | 1.97 x | 2.35 x | 11.3 x | 47.2 x | 49.4 x |
Nbr of stocks (in thousands) | 1,000,000 | 1,000,000 | 1,150,000 | 1,150,000 | 1,150,000 |
Reference price 2 | 0.4950 | 0.3250 | 0.5000 | 0.7700 | 0.5100 |
Announcement Date | 7/23/19 | 8/3/20 | 7/29/21 | 7/28/22 | 7/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 773.3 | 852 | 654 | 227.3 | 296 | 305.5 |
EBITDA 1 | 89.05 | 93.07 | -18.55 | -118.2 | -28.05 | -7.917 |
EBIT 1 | 65.49 | 67.55 | -52.83 | -144.3 | -44.02 | -16.82 |
Operating Margin | 8.47% | 7.93% | -8.08% | -63.47% | -14.87% | -5.51% |
Earnings before Tax (EBT) 1 | 64.65 | 50.7 | -106.3 | -124 | -31.93 | -6.94 |
Net income 1 | 52.98 | 37.75 | -112.4 | -124.3 | -32.01 | -6.94 |
Net margin | 6.85% | 4.43% | -17.18% | -54.67% | -10.81% | -2.27% |
EPS 2 | 0.0706 | 0.0483 | -0.1124 | -0.1158 | -0.0278 | -0.006034 |
Free Cash Flow 1 | 36.18 | 34.44 | 33.05 | -0.589 | 51.52 | 47.42 |
FCF margin | 4.68% | 4.04% | 5.05% | -0.26% | 17.41% | 15.52% |
FCF Conversion (EBITDA) | 40.63% | 37.01% | - | - | - | - |
FCF Conversion (Net income) | 68.29% | 91.25% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 1/14/19 | 7/23/19 | 8/3/20 | 7/29/21 | 7/28/22 | 7/31/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 407 | 255 | 157 | 80.2 |
Net Cash position 1 | 69.5 | 212 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | -21.92 x | -2.161 x | -5.6 x | -10.13 x |
Free Cash Flow 1 | 36.2 | 34.4 | 33.1 | -0.59 | 51.5 | 47.4 |
ROE (net income / shareholders' equity) | 57.4% | 20.9% | -57.8% | -131% | -92.1% | -45.3% |
ROA (Net income/ Total Assets) | 14.4% | 11.7% | -5.48% | -13.9% | -6.31% | -3.55% |
Assets 1 | 368.6 | 323.8 | 2,051 | 897 | 507.6 | 195.6 |
Book Value Per Share 2 | 0.1500 | 0.2500 | 0.1400 | 0.0400 | 0.0200 | 0.0100 |
Cash Flow per Share 2 | 0.1500 | 0.2400 | 0.1200 | 0.1300 | 0.0700 | 0.0800 |
Capex 1 | 24 | 35.1 | 43.7 | 12 | 3.2 | 2.6 |
Capex / Sales | 3.11% | 4.12% | 6.68% | 5.3% | 1.08% | 0.85% |
Announcement Date | 1/14/19 | 7/23/19 | 8/3/20 | 7/29/21 | 7/28/22 | 7/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 7.07M | |
+35.42% | 11.06B | |
+18.51% | 8.76B | |
+7.73% | 2.28B | |
-14.14% | 2.01B | |
+11.77% | 1.99B | |
+12.80% | 1.8B | |
-0.46% | 1.47B | |
-17.15% | 903M | |
-2.64% | 820M |
- Stock Market
- Equities
- 1703 Stock
- Financials Welife Technology Limited